MKI67 and breast carcinoma: PET tracer of 3’-deoxy-3’-[18F] fluorothymidine (FLT) has been shown to correlate with Ki-67 in breast cancer (10), but causes myelosuppression, peripheral neuropathy and nausea at high doses (7).